Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of the cancer-associated field of injury in the nasal epithelium in never-smokers.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Evaluating the robustness of features generated by a foundation model from CT with different reconstruction parameters.

Proceedings of SPIE--the International Society for Optical Engineering·2026
Same author

Modeling Workflow, Operational, and Financial Implications of AI-Enabled Same-Day Diagnostic Follow-Up for Screening Mammograms.

Proceedings of SPIE--the International Society for Optical Engineering·2026
Same author

Toward the simultaneous detection of multiple diseases with a highly cost-effective cell-free DNA methylome test.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Reducing demographic bias in biomedical machine learning for cancer detection using cfDNA methylation.

Genome biology·2026
Same author

Semi-Supervised Domain Adaptation with Latent Diffusion for Pathology Image Classification.

ArXiv·2026

Related Experiment Video

Updated: May 9, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

A formal representation for numerical data presented in published clinical trial reports.

Maurine Tong1, William Hsu, Ricky K Taira

  • 1Department of Bioengineering, University of California, Los Angeles.

Studies in Health Technology and Informatics
|August 8, 2013
PubMed
Summary

This study introduces a formal method and computational tools to standardize numerical data from clinical trial reports, enhancing evidence-based medicine. The approach aids in assessing trial quality and significance, particularly for non-small cell lung cancer (NSCLC) studies.

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Related Experiment Videos

Last Updated: May 9, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Area of Science:

  • Biomedical Informatics
  • Clinical Trial Methodology
  • Data Standardization

Background:

  • Evidence-based medicine relies on robust assessment and integration of clinical trial reports.
  • Numerical data within these reports is critical for evaluating study strength and quality.
  • Standardizing this data is essential for accurate interpretation and application.

Purpose of the Study:

  • To present a formal representation for standardizing numerical data from clinical trial reports.
  • To describe the development of computational tools for capturing and visualizing this standardized data.
  • To demonstrate the utility of this approach using non-small cell lung cancer (NSCLC) trial reports.

Main Methods:

  • Developed a formal representation incorporating a process model for experimental context.
  • Utilized a spreadsheet-based tool for organizing numerical data.
  • Applied the representation to published non-small cell lung cancer (NSCLC) clinical trial reports.

Main Results:

  • The proposed representation effectively captures reported numerical information from clinical trial papers.
  • A preliminary evaluation indicated the formalism's usefulness in identifying trial characteristics, quality, and significance.
  • Developed computational tools to aid in the capture and visualization of standardized data.

Conclusions:

  • The developed formal representation is sufficiently expressive for standardizing numerical data in clinical trial reports.
  • This approach facilitates a more rigorous assessment of clinical trial quality and significance.
  • The methodology supports the advancement of evidence-based medicine through improved data integration.